Wellington Management Group
SYRS

Wellington Management Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Wellington Management Group’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-103,086
Closed -$13.4M – 2332
2018
Q1 		$13.4M Buy
103,086
+3,408
+3% +$373K ﹤0.01% 1193
2017
Q4 		$9.7M Buy
99,678
+82
+0.1% +$11K ﹤0.01% 1283
2017
Q3 		$14.7M Buy
99,596
+87
+0.1% +$16.4K ﹤0.01% 1173
2017
Q2 		$16M Buy
+99,509
New +$15.6M ﹤0.01% 1103

Other funds holding SYRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return